The table below shows Progyny, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$210.19M
$179.10M
$188.81M
$80.39M
$26.04M
$36.20M
Capital expenditure
$18.41M
$5.41M
$3.64M
$3.24M
$2.13M
$1.04M
Investing cash flow
-$159.01M
$195.79M
-$200.53M
-$43.87M
$8.77M
-$40.03M
Dividends paid
-
-
-
-
-
-
PGNY operating cash flow (10-K history)
Progyny, Inc. reported operating cash flow of $210.19M for fiscal year 2025. That is up 17.4% from $179.10M in fiscal 2024. Over the 9 fiscal years shown, operating cash flow grew from -$9.47M (FY 2017) to $210.19M. Figures come from the company's audited annual reports as filed with the SEC.
